Catalyst Event
Lululemon Athletica Inc (LULU) · Earnings Release
From KEDI Global Obesity Care Industry Top 2+ Index (OBCI)
3/17/2026, 12:00:00 AM
Reported Q4 2025 EPS of $5.01, beating estimates, but provided weak guidance for Q1 and full-year 2026. Q1 EPS guidance of $1.63-$1.68 was significantly below the consensus of $2.07. High importance estimated due to significant guidance miss.
Korean Translation
2025년 4분기 주당순이익(EPS)이 5.01달러로 예상치를 상회했으나, 2026년 1분기 및 연간 실적 가이던스가 약하게 제시됨. 가이던스가 컨센서스를 크게 하회하여 10% 이상의 주가 하락이 예상됨.
Related Recent Events
Lululemon Athletica Inc (LULU) · Earnings Release
Q1 2026 earnings release scheduled. This is an estimated date based on past reporting schedules.
5/28/2026, 12:00:00 AM
Eli Lilly and Co (LLY) · Earnings Release
Q1 2026 earnings release scheduled; a price impact of at least 1% is expected.
4/30/2026, 12:00:00 AM
Abbott Laboratories (ABT) · Earnings Release
Q1 2026 earnings release with adjusted EPS guidance of $1.12 to $1.18, for which a ≥1% price impact is estimated, scheduled.
4/15/2026, 12:00:00 AM
Abbott Laboratories (ABT) · Other
Quarterly dividend ex-date of $0.63 per share on 2026-04-15, for which a ≥1% price impact is estimated, scheduled.
4/15/2026, 12:00:00 AM
Eli Lilly and Co (LLY) · Other
New target action date for the FDA's decision on oral obesity drug orforglipron, following an extension of the review period announced on January 15, 2026, scheduled; a price impact of at least 1% is expected.
4/10/2026, 12:00:00 AM
DICK'S Sporting Goods Inc (DKS) · Other
Quarterly dividend of $1.25 per share, a 3% increase, will have its ex-dividend date on March 27, 2026. The dividend is payable on April 10, 2026. A 1% price impact is estimated due to the dividend increase, scheduled.
3/27/2026, 12:00:00 AM